RCKT logo

ROCKET PHARMACEUTICALS INC

RCKTNASDAQ
🏆 #2903 by market capEarnings Nov 4 · PostUS Equity
$3.47▼ $0.03 (−1.00%)
Live
1h▼ 0.4%
24h▼ 1.0%
7d▼ 1.0%
14d▲ 10.5%
30d▼ 6.9%
1y▲ 18.9%
🏦Market Cap
$378M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
43
Weak
📊

Analyst Ratings

Price
$3.47
Total
19
Raised
0
Lowered
3
Avg PT
$23.81
H / L
$69 / $2
InstitutionActionRatingDate
Chardan Capital
ReiteratedBuy2026-05-11
B of A Securities
ReiteratedBuy2026-03-30
Goldman Sachs
ReiteratedSell2026-03-02
Cantor Fitzgerald
ReiteratedOverweight2026-02-27
JP Morgan
DowngradedOverweight → Underweight2025-11-18
Leerink Partners
ReiteratedMarket Perform2025-10-03
Canaccord Genuity
ReiteratedBuy2025-07-25
Needham
ReiteratedHold2025-07-24
UBS
ReiteratedBuy2025-06-17
Jefferies
DowngradedBuy → Hold2025-05-28
Scotiabank
ReiteratedSector Outperform2025-05-28
BMO Capital
ReiteratedOutperform2025-05-28
Wedbush
ReiteratedOutperform2025-05-16
Stifel
ReiteratedBuy2023-09-13
Raymond James
ReiteratedOutperform2023-05-05
SVB Leerink
ReiteratedOutperform2023-01-23
Evercore ISI Group
ReiteratedOutperform2022-09-30
Oppenheimer
DowngradedOutperform → Perform2020-12-08
Baird
ReiteratedOutperform2019-12-06
One row per institution, most recent rating